Harnessing Risk-Based Quality Management and Deep Learning to Improve Trial Knowledge and Drive Better Decision-Making and Outcomes
RBQM Doesn't have to be Complicated, Risky, or Expensive!
Beyond COVID-19: The New Normal In RBM & RBQM
Leveraging Analytics to Drive RBQM; The Role Biostatistics in Fraud Detection
The Importance of Early Risk Detection (with a Special Feature Addressing COVID-19)
ICH E6 (R2) Implementation Webinar Series: Part Two
ICH E6 (R2) Implementation Webinar Series: Part One
Risk-Based Monitoring for All
Implementing RBM - What Does ICH E6 (R2) Mean for Me and My Company?
Secrets of Successful Risk-Based Monitoring Revealed
Removing the Risk in Risk-Based Monitoring
The Complete Integrated Risk-Based Monitoring Solution
De-Risking it All - A Systematic and Proven Approach to RBM and Data Quality Oversight
Risk-Based Monitoring - What We've Learned in a Year, a Large Pharma Perspective from Sanofi
Risk-Based Monitoring and Central Statistical Monitoring
Risk-Based Monitoring Improves Data Quality - It's a Fact!
Removing the Risk in Risk-Based Monitoring - A Practical and Proven Approach to Implementing Central Statistical Monitoring
October 5-7, 2023: SCDM US 2023
November 1-2, 2023: OCT New England
November 8-11, 2023: CNS Summit
October 17-18, 2023: SCOPE EU
Got a Question?
Whether you’re looking to get started or need support, we’re here to help!
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
7,000
Platform Users
1,200
Studies De-Risked
100,000
Issues Detected